Fibroblast-adapted human CMV vaccines elicit predominantly conventional CD8 T cell responses in humans

Author(s):
Murray, S.E.; Nesterenko, P.A.; Vanarsdall, A.L.; Munks, M.W.; Smart, S.M.; Veziroglu, E.M.; Sagario, L.C.; Lee, R.; Claas, F.H.J. (0000-0003-4157-6201); Doxiadis, I.I.N.; Mcvoy, M.A.; Adler, S.P.; Hill, A.B.
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-07-31
Language
English
Is part of
Journal of Experimental Medicine (2017), Vol. 214, no. 7, p. 1889-1899
hdl
1887/115934
doi
10.1084/jem.20161988